GlassScriptPhysician profile
Carl W Decker
NPI 1154421279
$629.36
in general payments reported to CMS, 2019-2025
16 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.72 · 2021: $44.74 · 2022: $85.87 · 2023: $144 · 2024: $154 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $122.11 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Lunit Americas, INC. | $72.23 | 2025 | |
| Abbott Laboratories | $63.02 | 2022-2024 | Freestyle Libre 3, Freestyle Libre |
| Edwards Lifesciences Corporation | $52.92 | 2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Lilly USA, LLC | $47.72 | 2024-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $47.41 | 2019-2023 | Rexulti |
| Glaxosmithkline, LLC. | $38.95 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $35.31 | 2025 | Airsupra |
| Mckesson Medical-Surgical, INC. | $32.37 | 2021-2022 | |
| Medtronic, INC. | $29.75 | 2021 | |
| Amgen INC. | $16.35 | 2025 | Repatha |
| Sanofi Pasteur INC. | $15.15 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.69 | 2023 | Xifaxan, Trulance |
| Phathom Pharmaceuticals, INC. | $14.22 | 2024 | Voquezna |
| Sumitomo Pharma America, INC. | $13.59 | 2023 | Gemtesa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.